Literature DB >> 17922836

Analysis of the CK2-dependent phosphorylation of serine 13 in Cdc37 using a phospho-specific antibody and phospho-affinity gel electrophoresis.

Yoshihiko Miyata1, Eisuke Nishida.   

Abstract

The CK2-dependent phosphorylation of Ser13 in cell division cycle protein 37 (Cdc37), a kinase-specific heat shock protein 90 (Hsp90) cochaperone, has previously been reported to be essential for the association of Cdc37 with signaling protein kinases [Bandhakavi S, McCann RO, Hanna DE & Glover CVC (2003) J Biol Chem278, 2829-2836; Shao J, Prince T, Hartson SD & Matts RL (2003) J Biol Chem278, 38117-38220; Miyata Y & Nishida E (2004) Mol Cell Biol24, 4065-4074]. Here we describe a new phospho-specific antibody against Cdc37 that recognizes recombinant purified Cdc37 only when incubated with CK2 in the presence of Mg(2+) and ATP. The replacement of Ser13 in Cdc37 by nonphosphorylatable amino acids abolished binding to this antibody. The antibody was specific for phosphorylated Cdc37 and did not crossreact with other CK2 substrates such as Hsp90 and FK506-binding protein 52. Using this antibody, we showed that complexes of Hsp90 with its client signaling kinases, Cdk4, MOK, v-Src, and Raf1, contained the CK2-phosphorylated form of Cdc37 in vivo. Immunofluorescent staining showed that Hsp90 and the phosphorylated form of Cdc37 accumulated in epidermal growth factor-induced membrane ruffles. We further characterized the phosphorylation of Cdc37 using phospho-affinity gel electrophoresis. Our analyses demonstrated that the CK2-dependent phosphorylation of Cdc37 on Ser13 caused a specific gel mobility shift, and that Cdc37 in the complexes between Hsp90 and its client signaling protein kinases was in the phosphorylated form. Our results show the physiological importance of CK2-dependent Cdc37 phosphorylation and the usefulness of phospho-affinity gel electrophoresis in protein phosphorylation analysis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17922836     DOI: 10.1111/j.1742-4658.2007.06090.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  10 in total

1.  Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine.

Authors:  Wanping Xu; Mehdi Mollapour; Chrisostomos Prodromou; Suiquan Wang; Bradley T Scroggins; Zach Palchick; Kristin Beebe; Marco Siderius; Min-Jung Lee; Anthony Couvillon; Jane B Trepel; Yoshihiko Miyata; Robert Matts; Len Neckers
Journal:  Mol Cell       Date:  2012-06-21       Impact factor: 17.970

2.  Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE.

Authors:  Tomohisa Hosokawa; Taro Saito; Akiko Asada; Kohji Fukunaga; Shin-Ichi Hisanaga
Journal:  Mol Cell Proteomics       Date:  2010-01-23       Impact factor: 5.911

3.  Separation and detection of large phosphoproteins using Phos-tag SDS-PAGE.

Authors:  Eiji Kinoshita; Emiko Kinoshita-Kikuta; Tohru Koike
Journal:  Nat Protoc       Date:  2009-09-24       Impact factor: 13.491

4.  Threonine 22 phosphorylation attenuates Hsp90 interaction with cochaperones and affects its chaperone activity.

Authors:  Mehdi Mollapour; Shinji Tsutsumi; Andrew W Truman; Wanping Xu; Cara K Vaughan; Kristin Beebe; Anna Konstantinova; Srinivas Vourganti; Barry Panaretou; Peter W Piper; Jane B Trepel; Chrisostomos Prodromou; Laurence H Pearl; Len Neckers
Journal:  Mol Cell       Date:  2011-03-18       Impact factor: 17.970

5.  Phosphorylated and unphosphorylated serine 13 of CDC37 stabilize distinct interactions between its client and HSP90 binding domains.

Authors:  Wenjun Liu; Ralf Landgraf
Journal:  Biochemistry       Date:  2015-02-11       Impact factor: 3.162

6.  Evaluating CK2 activity with the antibody specific for the CK2-phosphorylated form of a kinase-targeting cochaperone Cdc37.

Authors:  Yoshihiko Miyata; Eisuke Nishida
Journal:  Mol Cell Biochem       Date:  2008-06-20       Impact factor: 3.396

Review 7.  The therapeutic target Hsp90 and cancer hallmarks.

Authors:  Yoshihiko Miyata; Hitoshi Nakamoto; Len Neckers
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  Antitumoral activity of allosteric inhibitors of protein kinase CK2.

Authors:  Virginie Moucadel; Renaud Prudent; Céline F Sautel; Florence Teillet; Caroline Barette; Laurence Lafanechere; Veronique Receveur-Brechot; Claude Cochet
Journal:  Oncotarget       Date:  2011-12

9.  Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours.

Authors:  Mengyuan Huang; Wenyu Yang; Jiaqing Zhu; Adrián Mariño-Enríquez; Chennianci Zhu; Jiaming Chen; Yuehong Wu; Yanping Quan; Haibo Qiu; Xuhui Li; Li Chai; Jonathan A Fletcher; Wen-Bin Ou
Journal:  Br J Cancer       Date:  2019-11-28       Impact factor: 7.640

10.  Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37.

Authors:  Cara K Vaughan; Mehdi Mollapour; Jennifer R Smith; Andrew Truman; Bin Hu; Valerie M Good; Barry Panaretou; Len Neckers; Paul A Clarke; Paul Workman; Peter W Piper; Chrisostomos Prodromou; Laurence H Pearl
Journal:  Mol Cell       Date:  2008-09-26       Impact factor: 17.970

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.